Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
IF-Pharma Oy
OY
Active
Y-tunnus 1071264-2
Itämerenkatu 21, 00180
Helsinki
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 1996 · 29 years old
1 employees
www.zaza.fi
Share
Finland
/
Companies
/
Retail sale of medical and orthopaedic goods
/
IF-Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
28M
55M
83M
110M
0M
2021
0M
2022
96M
2023
1M
2024
1M
2025
EBITDA
EUR millions
31M
23M
16M
8M
0M
0M
2021
0M
0%
2022
25M
+2500%
2023
0M
-100%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
0
256
95 563
923
1 013
Staff expenses
—
—
−0
−0
−0
EBITDA
−1
64
24 715
268
309
Depreciation & amort.
—
—
−0
−0
−0
EBIT
−1
64
24 715
268
309
Net financials
0
0
−0
0
−0
Profit before tax
−1
77
24 704
268
309
Tax
−0
13
49
54
62
Net profit
−1
64
19 758
214
247
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
14
385
38 746
338
370
Equity
14
78
27 562
290
307
Long-term debt
—
—
0
0
0
Short-term debt
0
307
11 183
48
63
Total debt
0
307
11 183
48
63
Financial ratios
5-year trend
EBITDA-margin
30.5%
This company
15.8%
Market median
+93% vs market
2021
2025
Soliditetsgrad
82.9%
This company
38.2%
Market median
+117% vs market
2021
2025
Egenkapitalforrentning
80.5%
This company
18.4%
Market median
+338% vs market
2021
2025
Nettoresultatgrad
24.4%
This company
8.1%
Market median
+201% vs market
2021
2025
Aktivomsætning
2.74×
This company
1.12×
Market median
+145% vs market
2021
2025
Gæld/egenkapital
0.21×
This company
0.62×
Market median
+66% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on IF-Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
